0001493152-23-000221.txt : 20230104 0001493152-23-000221.hdr.sgml : 20230104 20230104083017 ACCESSION NUMBER: 0001493152-23-000221 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD CENTRAL INDEX KEY: 0001120478 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41583 FILM NUMBER: 23504437 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 4 1 ownership.xml X0306 4 2023-01-03 0 0001835022 Coya Therapeutics, Inc. COYA 0001120478 GOLDSTEIN DOV A MD 5850 SAN FELIPE ST., SUITE 500 HOUSTON, TX 77057 1 0 0 0 Common Stock, par value $0.0001 per share 2023-01-03 4 P 0 10000 A 10000 D Warrant to Purchase Common Stock 7.50 2023-01-03 4 P 0 5000 A 2023-01-03 2025-01-03 Common Stock, par value $0.0001 per share 5000 5000 D Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant. /s/ David Snyder, Attorney-in-Fact 2023-01-04